137 related articles for article (PubMed ID: 25527465)
1. Radiological imaging features and clinicopathological correlation of hemosiderotic fibrolipomatous tumor: experience in a single tertiary cancer center.
O'Driscoll D; Athanasian E; Hameed M; Hwang S
Skeletal Radiol; 2015 May; 44(5):641-8. PubMed ID: 25527465
[TBL] [Abstract][Full Text] [Related]
2. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
3. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
Antonescu CR; Zhang L; Nielsen GP; Rosenberg AE; Dal Cin P; Fletcher CD
Genes Chromosomes Cancer; 2011 Oct; 50(10):757-64. PubMed ID: 21717526
[TBL] [Abstract][Full Text] [Related]
4. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
5. The t(1;10)(p22;q24) TGFBR3/MGEA5 Translocation in Pleomorphic Hyalinizing Angiectatic Tumor, Myxoinflammatory Fibroblastic Sarcoma, and Hemosiderotic Fibrolipomatous Tumor.
Liu H; Sukov WR; Ro JY
Arch Pathol Lab Med; 2019 Feb; 143(2):212-221. PubMed ID: 29979612
[TBL] [Abstract][Full Text] [Related]
6. Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot.
Agaimy A; Meidenbauer N; Sukov WR; Stoehr R; Vieth M; Roemer F; Grützmann R; Folpe AL
Virchows Arch; 2022 May; 480(5):1115-1120. PubMed ID: 34389899
[TBL] [Abstract][Full Text] [Related]
7. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
[TBL] [Abstract][Full Text] [Related]
8. Hemosiderotic Fibrolipomatous Tumor, Pleomorphic Hyalinizing Angiectatic Tumor, and Myxoinflammatory Fibroblastic Sarcoma: Related or Not?
Boland JM; Folpe AL
Adv Anat Pathol; 2017 Sep; 24(5):268-277. PubMed ID: 28375867
[TBL] [Abstract][Full Text] [Related]
9. Cytologic and Histologic Features of Pleomorphic Undifferentiated Sarcoma Arising in a Hybrid Hemosiderotic Fibrolipomatous Tumor and Pleomorphic Hyalinizing Angiectatic Tumor: Report of an Unusual Case with a Literature Review.
Morency E; Laskin W; Lin X
Acta Cytol; 2015; 59(6):493-7. PubMed ID: 26841226
[TBL] [Abstract][Full Text] [Related]
10. Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link.
Elco CP; Mariño-Enríquez A; Abraham JA; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Nov; 34(11):1723-7. PubMed ID: 20871391
[TBL] [Abstract][Full Text] [Related]
11. Case report: hemosiderotic fibrohistiocytic lipomatous lesion: a clinicopathologic characterization.
Moretti VM; Brooks JS; Ogilvie CM
Clin Orthop Relat Res; 2010 Oct; 468(10):2808-13. PubMed ID: 20127213
[TBL] [Abstract][Full Text] [Related]
12. Primary hemosiderotic fibrolipomatous tumor in bone: a case report and review of the literature.
Hou W; Li C; Guo C; Zhang L; Meng X; Liu Q; Wang J
Int J Clin Exp Pathol; 2018; 11(5):2497-2505. PubMed ID: 31938362
[No Abstract] [Full Text] [Related]
13. SNP array and FISH findings in two pleomorphic hyalinizing angiectatic tumors.
Mohajeri A; Kindblom LG; Sumathi VP; Brosjö O; Magnusson L; Nilsson J; Nord KH; Mertens F
Cancer Genet; 2012 Dec; 205(12):673-6. PubMed ID: 23177593
[TBL] [Abstract][Full Text] [Related]
14. Myxoinflammatory Fibroblastic Sarcoma: Review and Update.
Lucas DR
Arch Pathol Lab Med; 2017 Nov; 141(11):1503-1507. PubMed ID: 29072951
[TBL] [Abstract][Full Text] [Related]
15. Hemosiderotic fibrolipomatous tumor, not an entirely benign entity.
Solomon DA; Antonescu CR; Link TM; O'Donnell RJ; Folpe AL; Horvai AE
Am J Surg Pathol; 2013 Oct; 37(10):1627-30. PubMed ID: 24025526
[No Abstract] [Full Text] [Related]
16. Hemosiderotic fibrohistiocytic lipomatous lesion: ten cases of a previously undescribed fatty lesion of the foot/ankle.
Marshall-Taylor C; Fanburg-Smith JC
Mod Pathol; 2000 Nov; 13(11):1192-9. PubMed ID: 11106076
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic hyalinizing angiectatic tumor of soft parts: case report with unusual ganglion-like cells and review of the literature.
Changchien YC; Bocskai P; Kovács I; Hargitai Z; Kollár S; Török M
Pathol Res Pract; 2014 Dec; 210(12):1146-51. PubMed ID: 24857338
[TBL] [Abstract][Full Text] [Related]
18. [Staging and re-staging of soft tissue sarcoma using MRI. Usefulness of contrast media].
Barile A; Caulo M; Zugaro L; Di Cesare E; Gallucci M; Masciocchi C
Radiol Med; 2001 Jun; 101(6):444-55. PubMed ID: 11479441
[TBL] [Abstract][Full Text] [Related]
19. Haemosiderotic fibrolipomatous tumour (so-called haemosiderotic fibrohistiocytic lipomatous tumour): analysis of 13 new cases in support of a distinct entity.
Browne TJ; Fletcher CD
Histopathology; 2006 Mar; 48(4):453-61. PubMed ID: 16487368
[TBL] [Abstract][Full Text] [Related]
20. Novel Cytogenetic Characterization of Pleomorphic Hyalinizing Angiectatic Tumor (PHAT).
Rankins C; Covington JD; Devitt K; Kalof A; Goetz R; Gardner JA
J Assoc Genet Technol; 2019; 45(3):116-120. PubMed ID: 31554742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
